Autonomix Medical, Inc. — Form 8-K
Filed July 15, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 41/100
What the filing says
On July 13, 2026, Autonomix Medical exercised Series C warrants issued November 19, 2025 with one investor. The investor exercised 428,731 warrants at reduced price of $6.00/share (vs. original exercise price), generating ~$2.6M gross proceeds. In return, the company issued two new warrant series (D-1 and D-2), each for 428,731 shares at $5.75/share, exercisable immediately, 5.5-year term. Company to file resale registration statement within 15 days.
Why this rating
At $6.3M market cap, $2.6M raise is ~41% of company value—material but not transformational. Warrant structure with immediate exercisability and resale rights is favorable to holder, dilutive to existing shareholders; modest near-term positive for cash.
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.